Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.
Identifieur interne : 001958 ( PubMed/Corpus ); précédent : 001957; suivant : 001959Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.
Auteurs : Kevin D. Shield ; D Maxwell Parkin ; David C. Whiteman ; Jürgen Rehm ; Vivian Viallon ; Claire Marant Micallef ; Paolo Vineis ; Lesley Rushton ; Freddie Bray ; Isabelle SoerjomataramSource :
- Current epidemiology reports [ 2196-2995 ] ; 2016.
Abstract
The proportions of new cancer cases and deaths that are caused by exposure to risk factors and that could be prevented are key statistics for public health policy and planning. This paper summarizes the methodologies for estimating, challenges in the analysis of, and utility of, population attributable and preventable fractions for cancers caused by major risk factors such as tobacco smoking, dietary factors, high body fat, physical inactivity, alcohol consumption, infectious agents, occupational exposure, air pollution, sun exposure, and insufficient breastfeeding. For population attributable and preventable fractions, evidence of a causal relationship between a risk factor and cancer, outcome (such as incidence and mortality), exposure distribution, relative risk, theoretical-minimum-risk, and counterfactual scenarios need to be clearly defined and congruent. Despite limitations of the methodology and the data used for estimations, the population attributable and preventable fractions are a useful tool for public health policy and planning.
DOI: 10.1007/s40471-016-0085-5
PubMed: 27547696
Links to Exploration step
pubmed:27547696Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.</title><author><name sortKey="Shield, Kevin D" sort="Shield, Kevin D" uniqKey="Shield K" first="Kevin D" last="Shield">Kevin D. Shield</name><affiliation><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Parkin, D Maxwell" sort="Parkin, D Maxwell" uniqKey="Parkin D" first="D Maxwell" last="Parkin">D Maxwell Parkin</name><affiliation><nlm:affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Whiteman, David C" sort="Whiteman, David C" uniqKey="Whiteman D" first="David C" last="Whiteman">David C. Whiteman</name><affiliation><nlm:affiliation>Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Rehm, Jurgen" sort="Rehm, Jurgen" uniqKey="Rehm J" first="Jürgen" last="Rehm">Jürgen Rehm</name><affiliation><nlm:affiliation>Social and Epidemiological Research Department, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Viallon, Vivian" sort="Viallon, Vivian" uniqKey="Viallon V" first="Vivian" last="Viallon">Vivian Viallon</name><affiliation><nlm:affiliation>Université de Lyon, Université Lyon 1, UMRESTTE IFSTTAR, UMRESTTE, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Micallef, Claire Marant" sort="Micallef, Claire Marant" uniqKey="Micallef C" first="Claire Marant" last="Micallef">Claire Marant Micallef</name><affiliation><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vineis, Paolo" sort="Vineis, Paolo" uniqKey="Vineis P" first="Paolo" last="Vineis">Paolo Vineis</name><affiliation><nlm:affiliation>HuGeF Foundation, Torino, Italy; MRC-PHE Center for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Rushton, Lesley" sort="Rushton, Lesley" uniqKey="Rushton L" first="Lesley" last="Rushton">Lesley Rushton</name><affiliation><nlm:affiliation>Faculty of Medicine, School of Public Health, Imperial College of London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name><affiliation><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Soerjomataram, Isabelle" sort="Soerjomataram, Isabelle" uniqKey="Soerjomataram I" first="Isabelle" last="Soerjomataram">Isabelle Soerjomataram</name><affiliation><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27547696</idno><idno type="pmid">27547696</idno><idno type="doi">10.1007/s40471-016-0085-5</idno><idno type="wicri:Area/PubMed/Corpus">001958</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001958</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.</title><author><name sortKey="Shield, Kevin D" sort="Shield, Kevin D" uniqKey="Shield K" first="Kevin D" last="Shield">Kevin D. Shield</name><affiliation><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Parkin, D Maxwell" sort="Parkin, D Maxwell" uniqKey="Parkin D" first="D Maxwell" last="Parkin">D Maxwell Parkin</name><affiliation><nlm:affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Whiteman, David C" sort="Whiteman, David C" uniqKey="Whiteman D" first="David C" last="Whiteman">David C. Whiteman</name><affiliation><nlm:affiliation>Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Rehm, Jurgen" sort="Rehm, Jurgen" uniqKey="Rehm J" first="Jürgen" last="Rehm">Jürgen Rehm</name><affiliation><nlm:affiliation>Social and Epidemiological Research Department, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Viallon, Vivian" sort="Viallon, Vivian" uniqKey="Viallon V" first="Vivian" last="Viallon">Vivian Viallon</name><affiliation><nlm:affiliation>Université de Lyon, Université Lyon 1, UMRESTTE IFSTTAR, UMRESTTE, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Micallef, Claire Marant" sort="Micallef, Claire Marant" uniqKey="Micallef C" first="Claire Marant" last="Micallef">Claire Marant Micallef</name><affiliation><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vineis, Paolo" sort="Vineis, Paolo" uniqKey="Vineis P" first="Paolo" last="Vineis">Paolo Vineis</name><affiliation><nlm:affiliation>HuGeF Foundation, Torino, Italy; MRC-PHE Center for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Rushton, Lesley" sort="Rushton, Lesley" uniqKey="Rushton L" first="Lesley" last="Rushton">Lesley Rushton</name><affiliation><nlm:affiliation>Faculty of Medicine, School of Public Health, Imperial College of London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name><affiliation><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Soerjomataram, Isabelle" sort="Soerjomataram, Isabelle" uniqKey="Soerjomataram I" first="Isabelle" last="Soerjomataram">Isabelle Soerjomataram</name><affiliation><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Current epidemiology reports</title><idno type="ISSN">2196-2995</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The proportions of new cancer cases and deaths that are caused by exposure to risk factors and that could be prevented are key statistics for public health policy and planning. This paper summarizes the methodologies for estimating, challenges in the analysis of, and utility of, population attributable and preventable fractions for cancers caused by major risk factors such as tobacco smoking, dietary factors, high body fat, physical inactivity, alcohol consumption, infectious agents, occupational exposure, air pollution, sun exposure, and insufficient breastfeeding. For population attributable and preventable fractions, evidence of a causal relationship between a risk factor and cancer, outcome (such as incidence and mortality), exposure distribution, relative risk, theoretical-minimum-risk, and counterfactual scenarios need to be clearly defined and congruent. Despite limitations of the methodology and the data used for estimations, the population attributable and preventable fractions are a useful tool for public health policy and planning.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">27547696</PMID><DateCreated><Year>2016</Year><Month>08</Month><Day>22</Day></DateCreated><DateRevised><Year>2017</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2196-2995</ISSN><JournalIssue CitedMedium="Print"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>09</Month></PubDate></JournalIssue><Title>Current epidemiology reports</Title><ISOAbbreviation>Curr Epidemiol Rep</ISOAbbreviation></Journal><ArticleTitle>Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.</ArticleTitle><Pagination><MedlinePgn>201-211</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40471-016-0085-5</ELocationID><Abstract><AbstractText>The proportions of new cancer cases and deaths that are caused by exposure to risk factors and that could be prevented are key statistics for public health policy and planning. This paper summarizes the methodologies for estimating, challenges in the analysis of, and utility of, population attributable and preventable fractions for cancers caused by major risk factors such as tobacco smoking, dietary factors, high body fat, physical inactivity, alcohol consumption, infectious agents, occupational exposure, air pollution, sun exposure, and insufficient breastfeeding. For population attributable and preventable fractions, evidence of a causal relationship between a risk factor and cancer, outcome (such as incidence and mortality), exposure distribution, relative risk, theoretical-minimum-risk, and counterfactual scenarios need to be clearly defined and congruent. Despite limitations of the methodology and the data used for estimations, the population attributable and preventable fractions are a useful tool for public health policy and planning.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shield</LastName><ForeName>Kevin D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parkin</LastName><ForeName>D Maxwell</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whiteman</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehm</LastName><ForeName>Jürgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Social and Epidemiological Research Department, Centre for Addiction and Mental Health, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viallon</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Université de Lyon, Université Lyon 1, UMRESTTE IFSTTAR, UMRESTTE, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Micallef</LastName><ForeName>Claire Marant</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vineis</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>HuGeF Foundation, Torino, Italy; MRC-PHE Center for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rushton</LastName><ForeName>Lesley</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, School of Public Health, Imperial College of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bray</LastName><ForeName>Freddie</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soerjomataram</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U58 DP004954</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Epidemiol Rep</MedlineTA><NlmUniqueID>101626185</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2012 Jun;13(6):607-15</RefSource><PMID Version="1">22575588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2010 Sep;46(14):2617-24</RefSource><PMID Version="1">20843490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2005 Feb;83(2):118-26</RefSource><PMID Version="1">15744404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2014 Aug 2;384(9941):427-37</RefSource><PMID Version="1">24797573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2011 Nov;22(11):2349-57</RefSource><PMID Version="1">21378201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1998 Nov 18;280(19):1690-1</RefSource><PMID Version="1">9832001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2015 Feb 3;112(3):580-93</RefSource><PMID Version="1">25422909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2003 Jul 26;362(9380):271-80</RefSource><PMID Version="1">12892956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Toxicol Environ Health. 1994 Jun;42(2):219-42</RefSource><PMID Version="1">8207757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Prev Soc Med. 1971 Nov;25(4):242-4</RefSource><PMID Version="1">5160433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(2):e32363</RefSource><PMID Version="1">22384230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prev Med. 2002 Sep;35(3):219-24</RefSource><PMID Version="1">12202063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 2010 May;105(5):817-43</RefSource><PMID Version="1">20331573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 Dec 6;105 Suppl 2:S66-9</RefSource><PMID Version="1">22158324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ Open. 2013 Oct 22;3(10):e003543</RefSource><PMID Version="1">24154517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2013 Sep;13(9):674-8</RefSource><PMID Version="1">23924644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Unio Int Contra Cancrum. 1953;9(3):531-41</RefSource><PMID Version="1">13124110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2004 Jan 1;159(1):1-16</RefSource><PMID Version="1">14693654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1992 May 23;339(8804):1268-78</RefSource><PMID Version="1">1349675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Public Health. 1998 Jan;88(1):15-9</RefSource><PMID Version="1">9584027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2000 Sep 9;321(7261):624-8</RefSource><PMID Version="1">10977847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2005 Nov 19;366(9499):1784-93</RefSource><PMID Version="1">16298215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Clin Exp Res. 2014 Aug;38(8):2297-306</RefSource><PMID Version="1">25156617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Glob Health. 2015 Dec;3(12):e746-57</RefSource><PMID Version="1">26497599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tob Control. 2009 Jun;18(3):183-9</RefSource><PMID Version="1">19179370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Res. 2013;35(2):155-73</RefSource><PMID Version="1">24881324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Methods Psychiatr Res. 2006;15(4):181-91</RefSource><PMID Version="1">17266014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1974 May;99(5):325-32</RefSource><PMID Version="1">4825599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2015 Jan;16(1):36-46</RefSource><PMID Version="1">25467404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1988 Dec;128(6):1185-97</RefSource><PMID Version="1">3057878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1998 Nov 21;317(7170):1411-22</RefSource><PMID Version="1">9822393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2009 Apr;136(4):1215-24, e1-2</RefSource><PMID Version="1">19250648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Occup Environ Med. 2004 Jan;61(1):2-7</RefSource><PMID Version="1">14691266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1977 May;105(5):488-95</RefSource><PMID Version="1">871121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Apr 17;375(9723):1355-64</RefSource><PMID Version="1">20338629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2008 Sep 30;5(9):e185</RefSource><PMID Version="1">18788891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 Feb 16;371(9612):569-78</RefSource><PMID Version="1">18280327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aust N Z J Public Health. 2015 Oct;39(5):458-63</RefSource><PMID Version="1">26437732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Public Health. 2006 Mar;96(3):398; author reply 398-9</RefSource><PMID Version="1">16449574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biometrics. 1976 Dec;32(4):829-49</RefSource><PMID Version="1">1009228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Epidemiol. 2015 Mar;25(3):155-61</RefSource><PMID Version="1">25498918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Health. 2007 Nov 28;6:38</RefSource><PMID Version="1">18045465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aust N Z J Public Health. 2015 Oct;39(5):477-84</RefSource><PMID Version="1">26437735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med Res Methodol. 2013 Feb 18;13:24</RefSource><PMID Version="1">23419127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiology. 1999 Sep;10(5):594-605</RefSource><PMID Version="1">10468439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Epidemiol. 2015 Mar;25(3):201-7</RefSource><PMID Version="1">25511307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 1994;72(3):429-45</RefSource><PMID Version="1">8062401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Addict Res. 2003 Jan;9(1):18-28</RefSource><PMID Version="1">12566794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2004 Apr 10;328(7444):861</RefSource><PMID Version="1">15006898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Feb 5;360(6):573-87</RefSource><PMID Version="1">19196674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1973 Mar;97(3):135-47</RefSource><PMID Version="1">4571279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 Dec 6;105 Suppl 2:S2-5</RefSource><PMID Version="1">22158314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2015 Dec 5;386(10010):2287-323</RefSource><PMID Version="1">26364544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Occup Med. 1992 Jul;34(7):718-21</RefSource><PMID Version="1">1494965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2007 Aug 25;335(7616):358-9</RefSource><PMID Version="1">17717337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Sep;111(2):297-302</RefSource><PMID Version="1">17932743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Methods Psychiatr Res. 2012 Mar;21(1):17-28</RefSource><PMID Version="1">22337654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Fam Physician. 2007 Mar 1;75(5):683-8</RefSource><PMID Version="1">17375514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1980 Sep;112(3):409-16</RefSource><PMID Version="1">7424889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2010 Apr;39(2):430-8</RefSource><PMID Version="1">20032265</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychol Bull. 2007 Sep;133(5):859-83</RefSource><PMID Version="1">17723033</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 Dec 6;105 Suppl 2:S77-81</RefSource><PMID Version="1">22158327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1988 Sep;58(3):392-6</RefSource><PMID Version="1">3179193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Melanoma Res. 1993 Dec;3(6):395-401</RefSource><PMID Version="1">8161879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2016 Mar 15;138(6):1380-7</RefSource><PMID Version="1">26455822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tob Control. 2003 Mar;12(1):79-85</RefSource><PMID Version="1">12612368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Community Health. 1982 Summer;7(4):292-309</RefSource><PMID Version="1">7130448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1981 Jun;66(6):1191-308</RefSource><PMID Version="1">7017215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Gastroenterol Hepatol. 2011 Jun;8(6):340-7</RefSource><PMID Version="1">21643038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2007 Dec 15;370(9604):2044-53</RefSource><PMID Version="1">18063027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chest. 1997 May;111(5):1414-6</RefSource><PMID Version="1">9149602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2005 Nov;16(9):1009-19</RefSource><PMID Version="1">16184466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Occup Environ Med. 2000 Jan;57(1):10-8</RefSource><PMID Version="1">10711264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1985 Nov;122(5):904-14</RefSource><PMID Version="1">4050778</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2011 Aug 02;8(11):669-76</RefSource><PMID Version="1">21808267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2009 Apr 28;6(4):e1000058</RefSource><PMID Version="1">19399161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aust N Z J Public Health. 2015 Oct;39(5):471-6</RefSource><PMID Version="1">26437734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2000 Jan 1;151(1):41-9</RefSource><PMID Version="1">10625172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2011 Sep;73(3):268-73</RefSource><PMID Version="1">21333375</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Mar 15;120(6):1336-43</RefSource><PMID Version="1">17192897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 1999 Aug 27;82(5):657-64</RefSource><PMID Version="1">10417762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2010 Feb 1;126(3):692-702</RefSource><PMID Version="1">19645011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 1998 Jul;93(7):991-1006</RefSource><PMID Version="1">9744130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2003 Mar 19;95(6):470-8</RefSource><PMID Version="1">12644540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2013 Jul 1;91(7):509-18</RefSource><PMID Version="1">23825878</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Etiology</Keyword><Keyword MajorTopicYN="Y">Incidence</Keyword><Keyword MajorTopicYN="Y">Mortality</Keyword><Keyword MajorTopicYN="Y">Neoplasms</Keyword><Keyword MajorTopicYN="Y">Population Attributable Fraction</Keyword><Keyword MajorTopicYN="Y">Prevention and control</Keyword><Keyword MajorTopicYN="Y">Risk</Keyword></KeywordList><CoiStatement>Conflict of InterestKevin D. Shield, D. Maxwell Parkin, David C. Whiteman, Jürgen Rehm, Vivian Viallon, Claire Marant Micallef, Paolo Vineis, Lesley Rushton, Freddie Bray, Isabelle Soerjomataram declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27547696</ArticleId><ArticleId IdType="doi">10.1007/s40471-016-0085-5</ArticleId><ArticleId IdType="pmc">PMC4990141</ArticleId><ArticleId IdType="mid">HHSPA807501</ArticleId></ArticleIdList><pmc-dir>nihms</pmc-dir>
</PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001958 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001958 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27547696
|texte= Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27547696" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |